October Consumer Research Confirms Pet Health Remains Non-Negotiable Household Priority

  • Post author:
  • Post published:
  • Post category:Sales & Growth

Latest U.S. Survey of 2,000+ Consumers Shows 93% of Pet Owners Maintained or Increased Pet Spending in Past Three Months, Omnichannel Shift Redefines PurchasingINDIANAPOLIS, Nov. 6, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN), today released findings…

Continue ReadingOctober Consumer Research Confirms Pet Health Remains Non-Negotiable Household Priority

Phase II Study of Ivonescimab in the Perioperative Setting for Resectable NSCLC Published in Nature Medicine

  • Post author:
  • Post published:
  • Post category:Sales & Growth

HONG KONG, Nov. 5, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that results from a Phase II clinical study evaluating its first-in-class PD-1/VEGF bispecific antibody ivonescimab in the perioperative treatment of resectable non-small cell lung cancer (NSCLC)…

Continue ReadingPhase II Study of Ivonescimab in the Perioperative Setting for Resectable NSCLC Published in Nature Medicine